Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Aventis antitumor agents act by inhibiting Ras farnesylation

March 23, 2001

Two patents issued to Novuspharma cover new antitumor agents

March 23, 2001

MediGene's NV-1020 shows good safety profile in phase I

March 23, 2001

Ligand updates Targretin development programs in NSCLC, breast cancer and psoriasis

March 23, 2001

FDA requests additional information to support Bexxar BLA

March 23, 2001

Yuhan researchers discover new series of protein farnesyltransferase inhibitors

March 22, 2001

Clinical evaluation of NeoPharm's LE-AON commences

March 22, 2001

New technique for creating altered tumor antigens for cancer vaccines

March 22, 2001

Semaxanib (SU-5416) combination therapy enters phase III for advanced colorectal cancer

March 22, 2001

Cytotoxic compounds emerge from research program at U. Barcelona

March 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...